China Promotes At-Home Blood-Pressure Checks
This article was originally published in PharmAsia News
China's Ministry of Health is promoting at-home blood-pressure monitors as part of its national day to put a spotlight on the problem of life-threatening hypertension. The promotional effort includes having regional health departments offer consulting services to show residents how to measure their own pressure. The ministry estimates 200 million Chinese, 15 percent of the population, have high blood pressure, but only about 30 percent know it. Of the patients treated for high blood pressure in China, only 30 percent take their own measurements, compared with 75 percent in Italy. (Click here for more
You may also be interested in...
Takeda launches blockbuster gastrointestinal drug vedolizumab in India, stepping up the tempo on the back of the local base provided by its acquisition of Shire. More expansion in the country appears to be in store for the Japanese firm.
The US FDA’s Circulatory System Devices advisory panel will meet on 27 October to discuss the review of the premarket approval application of Neovasc’s Reducer device, which is intended to treat angina. See what Neovasc’s CEO Fred Colen said about it here.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.